Rotavirus Vaccine
Economics of rotavirus gastroenteritis and vaccine in Europe are focus of review
Published in Vaccine Weekly, March 22nd, 2006
"Rotavirus is a major cause of gastroenteritis in children throughout Europe and the world. In addition to causing morbidity and mortality in children, rotavirus gastroenteritis (RVGE) creates a major economic burden on health care systems and families in Europe. The costs of hospital admissions for RVGE and nosocomial infections generate significant medical treatment costs throughout the region. Less information is available on the costs associated with less severe episodes and the costs borne by families,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-03-22)
More Articles from Vaccine Weekly
- Breast Cancer Vaccine
Breast cancer prognostic information is aided by monocyte chemotactic protein-1 - Chlamydia Vaccine
Chlamydia protection is better delivered by intranasal than transcutaneous vaccine - Escherichia Coli Vaccine
E. coli O157O-specific vaccine is safe and immunogenic in children - Tuberculosis Vaccine
Tuberculosis vaccine efficacy is affected by BCG strain and delivery route - Amebiasis Vaccine
Amebiasis vaccine is developed that blocks adherence - Apoptosis
Apoptosis of primary neurons is inhibited by varicella-zoster virus ORF63 - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
